Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring

doi:10.4254/wjh.v17.i12.114084

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 12

This Article

(41)

(40)

(0)

(10)

(1070)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Dec 27, 2025; 17(12): 114084
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.114084

Full Size Figure Download Figure

Figure 1 Challenges in the diagnosis of drug induced liver injury in patients with inflammatory bowel disease. AIH: Autoimmune hepatitis; LFT: Liver function test; MASLD: Metabolic dysfunction associated steatotic liver disease; PSC: Primary sclerosing cholangitis; RUCAM: Roussel Uclaf Causality Assessment Method; DILI: Drug induced liver injury; IBD: Inflammatory bowel disease.

Citation: Singh A, Bhardwaj A, Kaur H, Bawa A, Midha V, Sood A. Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring. World J Hepatol 2025; 17(12): 114084
URL: https://www.wjgnet.com/1948-5182/full/v17/i12/114084.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i12.114084

Singh A, Bhardwaj A, Kaur H, Bawa A, Midha V, Sood A. Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring. World J Hepatol 2025; 17(12): 114084 [PMID: 41479516 DOI: 10.4254/wjh.v17.i12.114084]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.